CT SB00202 | 2024 | General Assembly

Status

Completed Legislative Action
Spectrum:
Status: Passed on May 30 2024 - 100% progression
Action: 2024-05-30 - Signed by the Governor
Text: Latest bill text (Chaptered) [PDF]

Summary

To: (1) Allow a licensed manufacturer or wholesaler to sell a hypodermic needle or syringe to an advanced practice registered nurse, optometrist or physician assistant; (2) redefine "commissioner", "pharmaceutical manufacturer" and "pharmaceutical marketing firm" for the purposes of various statutes concerning pharmaceutical marketing; (3) eliminate a requirement that the Department of Consumer Protection annually analyze certain information submitted to the department concerning pharmaceutical marketing; (4) extend the date by which the department is required to submit an annual report concerning pharmaceutical marketing; (5) eliminate an overlapping prohibition concerning automatic reciprocal discipline of pharmacists; (6) modify the actions the Commissioner of Consumer Protection may take following a violation of certain statutes concerning pharmaceutical marketing; (7) require certain practitioners that dispense, administer or prescribe controlled substances to make certain records available to the department; and (8) make minor, technical and conforming changes to various statutes concerning prescription drug control.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Prescription Drug Control.

Sponsors


Roll Calls

2024-05-08 - House - House Roll Call Vote 239 (Y: 144 N: 2 NV: 0 Abs: 5) [PASS]
2024-04-30 - Senate - Senate Roll Call Vote 134 (Y: 35 N: 1 NV: 0 Abs: 0) [PASS]
2024-03-07 - Joint - GL Vote Tally Sheet (Joint Favorable Substitute) (Y: 22 N: 0 NV: 0 Abs: 1) [PASS]

History

DateChamberAction
2024-05-30SenateSigned by the Governor
2024-05-23SenateTransmitted by Secretary of the State to Governor
2024-05-23SenateTransmitted to the Secretary of State
2024-05-17SenatePublic Act 24-80
2024-05-08SenateIn Concurrence
2024-05-08HouseHouse Passed
2024-05-02HouseHouse Calendar Number 429
2024-05-02HouseFavorable Report, Tabled for the Calendar, House
2024-04-30SenateSenate Passed
2024-03-21SenateFile Number 74
2024-03-21SenateSenate Calendar Number 74
2024-03-21SenateFavorable Report, Tabled for the Calendar, Senate
2024-03-21SenateReported Out of Legislative Commissioners' Office
2024-03-15SenateReferred to Office of Legislative Research and Office of Fiscal Analysis 03/20/24 5:00 PM
2024-03-07SenateFiled with Legislative Commissioners' Office
2024-03-07SenateJoint Favorable Substitute
2024-02-23SenatePublic Hearing 02/27
2024-02-22SenateReferred to Joint Committee on General Law

Connecticut State Sources


Bill Comments

feedback